FDA postmarket transformation plan
This article was originally published in The Gray Sheet
Executive Summary
A detailed report outlining implementation steps for CDRH's postmarket transformation initiative is due out in two weeks, said Susan Gardner, director, Office of Surveillance & Biometrics, during the Nov. 1 RAPS webcast. Announced in January, the four-point strategy aimed at enhancing the device center's surveillance techniques, focuses on agency collaboration, data sources and systems, risk communication, and compliance and enforcement (1"The Gray Sheet" Jan. 23, 2006, p. 5)...
You may also be interested in...
FDA Unveils Medical Device “Postmarket Transformation”
FDA's device center is establishing a senior-level team of agency staffers and outside experts to lead an effort to revitalize the postmarket device safety program, the agency announced Jan. 19
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.